Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study

https://cardiab.biomedcentral.com/articles/10.1186/s12933-019-0835-z

To ascertain the effects of dipeptidyl peptidase-4 inhibitor (DPP4i) on the possibility of important cardiocerebrovascular and renal effects compared with sulfonylurea (SU) along with metformin in patients with type 2…

Ryan
Ryan

No Comments

Write a Reply or Comment